Exploring mast cell disorders: Tryptases, hereditary alpha-tryptasemia, and MCAS treatment approaches.
作者信息
Bellanti Joseph A, Settipane Russell A
出版信息
Allergy Asthma Proc. 2025 Jan 1;46(1):1-3. doi: 10.2500/aap.2025.46.240102.
Abstract
摘要
相似文献
1
Exploring mast cell disorders: Tryptases, hereditary alpha-tryptasemia, and MCAS treatment approaches.探索肥大细胞疾病：类胰蛋白酶、遗传性α-类胰蛋白酶血症及肥大细胞活化综合征的治疗方法。
Allergy Asthma Proc. 2025 Jan 1;46(1):1-3. doi: 10.2500/aap.2025.46.240102.
2
Using the Right Criteria for MCAS.用正确的标准来诊断肥大细胞激活综合征（MCAS）。
Curr Allergy Asthma Rep. 2024 Feb;24(2):39-51. doi: 10.1007/s11882-024-01126-0. Epub 2024 Jan 20.
3
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review.选择正确的诊断标准和分类来诊断肥大细胞激活综合征：一项批判性综述。
J Allergy Clin Immunol Pract. 2021 Nov;9(11):3918-3928. doi: 10.1016/j.jaip.2021.06.011. Epub 2021 Jun 22.
4
Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders.703例疑似肥大细胞疾病患者中特发性肥大细胞活化综合征的低患病率
J Allergy Clin Immunol Pract. 2024 Mar;12(3):753-761. doi: 10.1016/j.jaip.2023.11.041. Epub 2023 Dec 4.
5
Appraisal of the evidence linking hereditary α-tryptasemia with mast cell disorders, hypermobility and dysautonomia.关于遗传性α-色氨酸血症与肥大细胞疾病、关节过度活动和自主神经功能障碍之间联系的证据评估。
Allergy Asthma Proc. 2025 Jan 1;46(1):4-10. doi: 10.2500/aap.2025.46.240088.
6
Mimics of Allergy and Angioedema: Scombroid, Mast Cell Activation Disorders, and Hereditary Alpha Tryptasemia.过敏和血管性水肿的模拟物：鲭鱼中毒、肥大细胞活化障碍和遗传性α-胰蛋白酶血症。
Immunol Allergy Clin North Am. 2023 Aug;43(3):553-568. doi: 10.1016/j.iac.2022.10.007.
7
Distinct Small Intestine Mast Cell Histologic Changes in Patients With Hereditary Alpha-tryptasemia and Mast Cell Activation Syndrome.遗传性α-胰蛋白酶血症和肥大细胞活化综合征患者的小肠肥大细胞组织学变化特征不同。
Am J Surg Pathol. 2021 Jul 1;45(7):997-1004. doi: 10.1097/PAS.0000000000001676.
8
Global Classification of Mast Cell Activation Disorders: An ICD-10-CM-Adjusted Proposal of the ECNM-AIM Consortium.全球肥大细胞活化障碍分类：ECNM-AIM 联盟的 ICD-10-CM 调整提案。
J Allergy Clin Immunol Pract. 2022 Aug;10(8):1941-1950. doi: 10.1016/j.jaip.2022.05.007. Epub 2022 May 25.
9
Patients with mast cell activation symptoms and elevated baseline serum tryptase level have unique bone marrow morphology.伴有肥大细胞活化症状和基础血清类胰蛋白酶水平升高的患者具有独特的骨髓形态。
J Allergy Clin Immunol. 2021 Apr;147(4):1497-1501.e1. doi: 10.1016/j.jaci.2020.11.017. Epub 2020 Nov 25.
10
Mast cell disorders are associated with decreased cerebral blood flow and small fiber neuropathy.肥大细胞疾病与脑血流减少和小纤维神经病有关。
Ann Allergy Asthma Immunol. 2022 Mar;128(3):299-306.e1. doi: 10.1016/j.anai.2021.10.006. Epub 2021 Oct 11.
引用本文的文献
1
Non allergic gastrointestinal manifestations of hereditary alpha-tryptasemia.遗传性α-色氨酸血症的非过敏性胃肠道表现
Front Allergy. 2025 Jun 10;6:1598309. doi: 10.3389/falgy.2025.1598309. eCollection 2025.
本文引用的文献
1
Idiopathic non-mast cell angioedema: Treatment insights from global experts.
Allergy Asthma Proc. 2025 Jan 1;46(1):38-44. doi: 10.2500/aap.2025.46.240091.
2
Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan.
Allergy Asthma Proc. 2025 Jan 1;46(1):59-69. doi: 10.2500/aap.2025.46.240092. Epub 2024 Nov 12.
3
Appraisal of the evidence linking hereditary α-tryptasemia with mast cell disorders, hypermobility and dysautonomia.关于遗传性α-色氨酸血症与肥大细胞疾病、关节过度活动和自主神经功能障碍之间联系的证据评估。
Allergy Asthma Proc. 2025 Jan 1;46(1):4-10. doi: 10.2500/aap.2025.46.240088.
4
Systematic review of omalizumab for refractory clonal and non-clonal mast cell activation syndrome.
Allergy Asthma Proc. 2025 Jan 1;46(1):11-18. doi: 10.2500/aap.2025.46.240076.
5
Evaluation of allergic diseases in children diagnosed with cutaneous mastocytosis.对诊断为皮肤肥大细胞增多症的儿童过敏性疾病的评估。
Allergy Asthma Proc. 2025 Jan 1;46(1):e1-e5. doi: 10.2500/aap.2025.46.240093.
6
Perioperative anaphylaxis manifesting as cardiac arrest during cardiac surgery.心脏手术期间表现为心脏骤停的围手术期过敏反应。
Allergy Asthma Proc. 2025 Jan 1;46(1):70-75. doi: 10.2500/aap.2025.46.240082.
7
Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab: A analysis of RELIght study.使用美泊利珠单抗治疗的重度嗜酸性粒细胞性哮喘患者的临床缓解：RELIght研究分析
Allergy Asthma Proc. 2025 Jan 1;46(1):45-51. doi: 10.2500/aap.2025.46.240084.
8
Allergen immunotherapy: How to stay current with USP 797 and practice guidelines.
Allergy Asthma Proc. 2025 Jan 1;46(1):26-31. doi: 10.2500/aap.2025.46.240078.
9
Efficacy of parenteral bronchodilators on ventilatory outcomes in pediatric critical asthma: a national cohort study.
Allergy Asthma Proc. 2025 Jan 1;46(1):e6-e12. doi: 10.2500/aap.2025.46.240099.
10
Atopic dermatitis: Best of guidelines and yardstick.特应性皮炎：最佳指南与标准
Allergy Asthma Proc. 2025 Jan 1;46(1):19-25. doi: 10.2500/aap.2025.46.240087.
Zotero 插件